title: A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
abstract: The Mn porphyrins of k(cat)(O(2)(.-)) as high as that of a superoxide dismutase enzyme and of optimized lipophilicity have already been synthesized. Their exceptional in vivo potency is at least in part due to their ability to mimic the site and location of mitochondrial superoxide dismutase, MnSOD. MnTnHex-2-PyP(5+) is the most studied among lipophilic Mn porphyrins. It is of remarkable efficacy in animal models of oxidative stress injuries and particularly in central nervous system diseases. However, when used at high single and multiple doses it becomes toxic. The toxicity of MnTnHex-2-PyP(5+) has been in part attributed to its micellar properties, i.e., the presence of polar cationic nitrogens and hydrophobic alkyl chains. The replacement of a CH(2) group by an oxygen atom in each of the four alkyl chains was meant to disrupt the porphyrin micellar character. When such modification occurs at the end of long alkyl chains, the oxygens become heavily solvated, which leads to a significant drop in the lipophilicity of porphyrin. However, when the oxygen atoms are buried deeper within the long heptyl chains, their excessive solvation is precluded and the lipophilicity preserved. The presence of oxygens and the high lipophilicity bestow the exceptional chemical and physical properties to Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin, MnTnBuOE-2-PyP(5+). The high SOD-like activity is preserved and even enhanced: log k(cat)(O(2)(.-))=7.83 vs 7.48 and 7.65 for MnTnHex-2-PyP(5+) and MnTnHep-2-PyP(5+), respectively. MnTnBuOE-2-PyP(5+) was tested in an O(2)(.-) -specific in vivo assay, aerobic growth of SOD-deficient yeast, Saccharomyces cerevisiae, where it was fully protective in the range of 5-30 μM. MnTnHep-2-PyP(5+) was already toxic at 5 μM, and MnTnHex-2-PyP(5+) became toxic at 30 μM. In a mouse toxicity study, MnTnBuOE-2-PyP(5+) was several-fold less toxic than either MnTnHex-2-PyP(5+) or MnTnHep-2-PyP(5+).
authors.affiliation: Department of Radiation Oncology, Duke University Medical Center, NC 27710, USA.
authors.forename: Zrinka
authors.initials: Z
authors.lastname: Rajic
authors.forename: Artak
authors.initials: A
authors.lastname: Tovmasyan
authors.forename: Ivan
authors.initials: I
authors.lastname: Spasojevic
authors.forename: Huaxin
authors.initials: H
authors.lastname: Sheng
authors.forename: Miaomiao
authors.initials: M
authors.lastname: Lu
authors.forename: Alice M
authors.initials: AM
authors.lastname: Li
authors.forename: Edith B
authors.initials: EB
authors.lastname: Gralla
authors.forename: David S
authors.initials: DS
authors.lastname: Warner
authors.forename: Ludmil
authors.initials: L
authors.lastname: Benov
authors.forename: Ines
authors.initials: I
authors.lastname: Batinic-Haberle
mesh_terms: D000818:Animals; D002384:Catalysis; D055664:Electrochemical Techniques; D008297:Male; D008665:Metalloporphyrins / Q000494:pharmacology* / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D008823:Micelles; D018716:Molecular Mimicry; D018384:Oxidative Stress; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D021241:Spectrometry, Mass, Electrospray Ionization; D013056:Spectrophotometry, Ultraviolet; D013482:Superoxide Dismutase / Q000378:metabolism*
chemical_list: D008665:Metalloporphyrins; D008823:Micelles; C575143:Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin; D013482:Superoxide Dismutase